Cti Biopharma Corp Stock
Your prediction
Pros and Cons of Cti Biopharma Corp in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cti Biopharma Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - | - | - | - |
| Jaguar Health Inc. | 31.840% | 26.894% | 146.626% | 157.033% | 33.113% | -99.929% | - |
| Vaxart Inc. | 0.520% | 2.123% | -43.898% | -8.517% | 30.625% | -92.490% | - |
| aTyr Pharma Inc | 2.100% | -2.667% | -20.219% | -17.045% | 13.178% | -56.287% | -82.264% |
Comments
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Show more
Ratings data for CTIC provided by MarketBeat
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Show more
Ratings data for CTIC provided by MarketBeat
